These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22028405)

  • 1. Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases.
    Dudbridge F; Fletcher O; Walker K; Johnson N; Orr N; Dos Santos Silva I; Peto J
    Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):262-72. PubMed ID: 22028405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.
    Zhang Y; Long J; Lu W; Shu XO; Cai Q; Zheng Y; Li C; Li B; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):622-8. PubMed ID: 24470074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
    Fachal L; Aschard H; Beesley J; Barnes DR; Allen J; Kar S; Pooley KA; Dennis J; Michailidou K; Turman C; Soucy P; Lemaçon A; Lush M; Tyrer JP; Ghoussaini M; Moradi Marjaneh M; Jiang X; Agata S; Aittomäki K; Alonso MR; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Aronson KJ; Arun BK; Auber B; Auer PL; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Beeghly-Fadiel A; Benitez J; Bermisheva M; Białkowska K; Blanco AM; Blomqvist C; Blot W; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borg A; Bosse K; Brauch H; Brenner H; Briceno I; Brock IW; Brooks-Wilson A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldés T; Caligo MA; Camp NJ; Campbell I; Canzian F; Carroll JS; Carter BD; Castelao JE; Chiquette J; Christiansen H; Chung WK; Claes KBM; Clarke CL; ; ; Collée JM; Cornelissen S; Couch FJ; Cox A; Cross SS; Cybulski C; Czene K; Daly MB; de la Hoya M; Devilee P; Diez O; Ding YC; Dite GS; Domchek SM; Dörk T; Dos-Santos-Silva I; Droit A; Dubois S; Dumont M; Duran M; Durcan L; Dwek M; Eccles DM; Engel C; Eriksson M; Evans DG; Fasching PA; Fletcher O; Floris G; Flyger H; Foretova L; Foulkes WD; Friedman E; Fritschi L; Frost D; Gabrielson M; Gago-Dominguez M; Gambino G; Ganz PA; Gapstur SM; Garber J; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Glendon G; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Tibiletti MG; Greene MH; Grip M; Gronwald J; Grundy A; Guénel P; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hartikainen JM; Hartman M; He W; Healey CS; Heemskerk-Gerritsen BAM; Heyworth J; Hillemanns P; Hogervorst FBL; Hollestelle A; Hooning MJ; Hopper JL; Howell A; Huang G; Hulick PJ; Imyanitov EN; ; ; ; Isaacs C; Iwasaki M; Jager A; Jakimovska M; Jakubowska A; James PA; Janavicius R; Jankowitz RC; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kang D; Kapoor PM; Karlan BY; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Kirk J; Kitahara CM; Ko YD; Konstantopoulou I; Kosma VM; Koutros S; Kubelka-Sabit K; Kwong A; Kyriacou K; Laitman Y; Lambrechts D; Lee E; Leslie G; Lester J; Lesueur F; Lindblom A; Lo WY; Long J; Lophatananon A; Loud JT; Lubiński J; MacInnis RJ; Maishman T; Makalic E; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Matsuo K; Maurer T; Mavroudis D; Mayes R; McGuffog L; McLean C; Mebirouk N; Meindl A; Miller A; Miller N; Montagna M; Moreno F; Muir K; Mulligan AM; Muñoz-Garzon VM; Muranen TA; Narod SA; Nassir R; Nathanson KL; Neuhausen SL; Nevanlinna H; Neven P; Nielsen FC; Nikitina-Zake L; Norman A; Offit K; Olah E; Olopade OI; Olsson H; Orr N; Osorio A; Pankratz VS; Papp J; Park SK; Park-Simon TW; Parsons MT; Paul J; Pedersen IS; Peissel B; Peshkin B; Peterlongo P; Peto J; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Presneau N; Prokofyeva D; Pujana MA; Pylkäs K; Radice P; Ramus SJ; Rantala J; Rau-Murthy R; Rennert G; Risch HA; Robson M; Romero A; Rossing M; Saloustros E; Sánchez-Herrero E; Sandler DP; Santamariña M; Saunders C; Sawyer EJ; Scheuner MT; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schöttker B; Schürmann P; Scott C; Scott RJ; Senter L; Seynaeve CM; Shah M; Sharma P; Shen CY; Shu XO; Singer CF; Slavin TP; Smichkoska S; Southey MC; Spinelli JJ; Spurdle AB; Stone J; Stoppa-Lyonnet D; Sutter C; Swerdlow AJ; Tamimi RM; Tan YY; Tapper WJ; Taylor JA; Teixeira MR; Tengström M; Teo SH; Terry MB; Teulé A; Thomassen M; Thull DL; Tischkowitz M; Toland AE; Tollenaar RAEM; Tomlinson I; Torres D; Torres-Mejía G; Troester MA; Truong T; Tung N; Tzardi M; Ulmer HU; Vachon CM; van Asperen CJ; van der Kolk LE; van Rensburg EJ; Vega A; Viel A; Vijai J; Vogel MJ; Wang Q; Wappenschmidt B; Weinberg CR; Weitzel JN; Wendt C; Wildiers H; Winqvist R; Wolk A; Wu AH; Yannoukakos D; Zhang Y; Zheng W; Hunter D; Pharoah PDP; Chang-Claude J; García-Closas M; Schmidt MK; Milne RL; Kristensen VN; French JD; Edwards SL; Antoniou AC; Chenevix-Trench G; Simard J; Easton DF; Kraft P; Dunning AM
    Nat Genet; 2020 Jan; 52(1):56-73. PubMed ID: 31911677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
    Dandine-Roulland C; Perdry H
    Eur J Hum Genet; 2015 Oct; 23(10):1357-63. PubMed ID: 25585700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between ovarian cancer susceptibility variants and breast cancer risk among Chinese women.
    Ma X; Cai Q; Delahanty RJ; Shu XO; Zhang B; Lu W; Gao YT; Zheng W; Long J; Beeghly-Fadiel A
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):467-9. PubMed ID: 23292081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of NuMA variation in breast cancer.
    Kilpivaara O; Rantanen M; Tamminen A; Aittomäki K; Blomqvist C; Nevanlinna H
    BMC Cancer; 2008 Mar; 8():71. PubMed ID: 18331640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of common single nucleotide polymorphisms synthesizing quantitative trait association of rarer causal variants.
    Takeuchi F; Kobayashi S; Ogihara T; Fujioka A; Kato N
    Genome Res; 2011 Jul; 21(7):1122-30. PubMed ID: 21441355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
    Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
    PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between genetic ancestry and common breast cancer susceptibility variants in Colombian women.
    Torres D; Lorenzo Bermejo J; Garcia Mesa K; Gilbert M; Briceño I; Pohl-Zeidler S; González Silos R; Boekstegers F; Plass C; Hamann U
    Int J Cancer; 2019 May; 144(9):2181-2191. PubMed ID: 30485434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSD17B1 genetic variants and hormone receptor-defined breast cancer.
    Gaudet MM; Chanock S; Dunning A; Driver K; Brinton LA; Lissowska J; Peplonska B; Pharoah P; Garcia-Closas M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2766-72. PubMed ID: 18843021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population.
    Lesueur F; Song H; Ahmed S; Luccarini C; Jordan C; Luben R; Easton DF; Dunning AM; Pharoah PD; Ponder BA
    Br J Cancer; 2006 Jun; 94(12):1921-6. PubMed ID: 16685266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities.
    Lindström S; Ablorh A; Chapman B; Gusev A; Chen G; Turman C; Eliassen AH; Price AL; Henderson BE; Le Marchand L; Hofmann O; Haiman CA; Kraft P
    Breast Cancer Res; 2016 Nov; 18(1):109. PubMed ID: 27814745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
    Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting signatures of "synthetic associations" and "natural associations" from empirical patterns of human genetic variation.
    Chang D; Keinan A
    PLoS Comput Biol; 2012; 8(7):e1002600. PubMed ID: 22792059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.